Envestnet Asset Management Inc. Acquires 99,979 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Envestnet Asset Management Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,239,866 shares of the healthcare conglomerate's stock after purchasing an additional 99,979 shares during the period. Envestnet Asset Management Inc. owned 0.25% of UnitedHealth Group worth $1,173,130,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of UNH. Citizens National Bank Trust Department raised its position in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH increased its position in shares of UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after acquiring an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $515,000. Full Sail Capital LLC increased its position in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after acquiring an additional 33 shares during the period. Finally, Soros Fund Management LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $39,413,000. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In related news, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director directly owned 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

UNH stock traded up $3.84 during midday trading on Tuesday, reaching $307.55. 2,489,077 shares of the company's stock traded hands, compared to its average volume of 7,546,935. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The stock has a market cap of $278.99 billion, a P/E ratio of 12.88, a PEG ratio of 1.48 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock's 50-day moving average is $322.66 and its 200 day moving average is $445.65.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the prior year, the company posted $6.91 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.87%. UnitedHealth Group's dividend payout ratio is 37.02%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on UNH. Robert W. Baird cut shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target on the stock. in a research report on Wednesday, June 11th. HSBC reiterated a "reduce" rating and set a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Mizuho dropped their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.